These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28280138)

  • 1. Sickle Cell Trait and the Risk of ESRD in Blacks.
    Naik RP; Irvin MR; Judd S; Gutiérrez OM; Zakai NA; Derebail VK; Peralta C; Lewis MR; Zhi D; Arnett D; McClellan W; Wilson JG; Reiner AP; Kopp JB; Winkler CA; Cushman M
    J Am Soc Nephrol; 2017 Jul; 28(7):2180-2187. PubMed ID: 28280138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
    Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
    Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals.
    Hyacinth HI; Franceschini N; Seals SR; Irvin MR; Chaudhary N; Naik RP; Alonso A; Carty CL; Burke GL; Zakai NA; Winkler CA; David VA; Kopp JB; Judd SE; Adams RJ; Gee BE; Longstreth WT; Egede L; Lackland DT; Greenberg CS; Taylor H; Manson JE; Key NS; Derebail VK; Kshirsagar AV; Folsom AR; Konety SH; Howard V; Allison M; Wilson JG; Correa A; Zhi D; Arnett DK; Howard G; Reiner AP; Cushman M; Safford MM
    JAMA Netw Open; 2021 Jan; 4(1):e2030435. PubMed ID: 33399855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study.
    Chen TK; Coresh J; Daya N; Ballew SH; Tin A; Crews DC; Grams ME
    J Am Geriatr Soc; 2021 Jan; 69(1):155-163. PubMed ID: 32894582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
    Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH
    Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial.
    Bodonyi-Kovacs G; Ma JZ; Chang J; Lipkowitz MS; Kopp JB; Winkler CA; Le TH
    J Am Soc Nephrol; 2016 Oct; 27(10):3140-3152. PubMed ID: 26940095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race, APOL1 Risk, and eGFR Decline in the General Population.
    Grams ME; Rebholz CM; Chen Y; Rawlings AM; Estrella MM; Selvin E; Appel LJ; Tin A; Coresh J
    J Am Soc Nephrol; 2016 Sep; 27(9):2842-50. PubMed ID: 26966015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.
    Peralta CA; Bibbins-Domingo K; Vittinghoff E; Lin F; Fornage M; Kopp JB; Winkler CA
    J Am Soc Nephrol; 2016 Mar; 27(3):887-93. PubMed ID: 26180129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
    Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
    Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sickle cell trait and end stage renal disease in Salvador, Brazil.
    Alladagbin DJ; Fernandes PN; Tavares MB; Brito JT; Oliveira GGS; Silva LK; Khouri NA; Oliveira MB; Amorim T; Matos CM; Ribeiro GS; Lopes AA; Gonçalves MS; Dos-Santos WLC
    PLoS One; 2018; 13(12):e0209036. PubMed ID: 30557319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.
    Ku E; Lipkowitz MS; Appel LJ; Parsa A; Gassman J; Glidden DV; Smogorzewski M; Hsu CY
    Kidney Int; 2017 Feb; 91(2):443-450. PubMed ID: 27927600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease.
    Fine DM; Wasser WG; Estrella MM; Atta MG; Kuperman M; Shemer R; Rajasekaran A; Tzur S; Racusen LC; Skorecki K
    J Am Soc Nephrol; 2012 Feb; 23(2):343-50. PubMed ID: 22135313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thirty-year risk of ischemic stroke in individuals with sickle cell trait and modification by chronic kidney disease: The atherosclerosis risk in communities (ARIC) study.
    Caughey MC; Derebail VK; Key NS; Reiner AP; Gottesman RF; Kshirsagar AV; Heiss G
    Am J Hematol; 2019 Dec; 94(12):1306-1313. PubMed ID: 31429114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin.
    Yium J; Gabow P; Johnson A; Kimberling W; Martinez-Maldonado M
    J Am Soc Nephrol; 1994 Mar; 4(9):1670-4. PubMed ID: 8011976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell trait and incident ischemic stroke in the Atherosclerosis Risk in Communities study.
    Caughey MC; Loehr LR; Key NS; Derebail VK; Gottesman RF; Kshirsagar AV; Grove ML; Heiss G
    Stroke; 2014 Oct; 45(10):2863-7. PubMed ID: 25139879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Young BA; Wilson JG; Reiner A; Kestenbaum B; Franceschini N; Bansal N; Correa A; Himmelfarb J; Katz R
    Kidney Med; 2021; 3(6):962-973.e1. PubMed ID: 34939005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
    Anyaegbu EI; Shaw AS; Hruska KA; Jain S
    Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Co-inheritance of autosomal dominant polycystic kidney disease and sickle cell trait in African Americans].
    Peces R; Peces C; Cuesta-López E; Vega-Cabrera C; Azorín S; Pérez-Dueñas V; Selgas R
    Nefrologia; 2011; 31(2):162-8. PubMed ID: 21461009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.